Latest Monoclonal antibodies Stories
MONROVIA, Calif., March 19, 2015 /PRNewswire/ -- Xencor, Inc.
DALLAS, March 18, 2015 /PRNewswire/ -- RnRMarketResearch.com adds "Methotrexate (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023" market research report provides
Pivotal Results Comparing Brodalumab With Stelara® (Ustekinumab) and Placebo to be Presented in Late-Breaking Session THOUSAND OAKS, Calif., March 17, 2015 /PRNewswire/ -- Amgen (NASDAQ:AMGN)
- 22 abstracts further evaluate the safety, efficacy of HUMIRA in psoriatic arthritis and moderate to severe chronic plaque psoriasis and investigational use of HUMIRA for the treatment of moderate
NantCell To Acquire Exclusive Rights to Antibodies Including CAR-TNK(TM) Products and the Checkpoint Inhibitors PD-1 and PD-L1 SAN DIEGO, Mar.
If authorized, SB2 will be marketed in Europe by Biogen Idec INCHEON, South Korea, March 13, 2015 /PRNewswire/ -- Samsung Bioepis Co., Ltd., today announced that the Marketing Authorization
DALLAS, March 13, 2015 /PRNewswire/ -- RnRMarketResearch.com adds "Hidradenitis Suppurativa - Pipeline Review, H1 2015" therapeutic market research report provides an overview
The global market for research antibodies reached $2 billion in 2013 and nearly $2.2 billion in 2014.
TAMPA, Fla., March 12, 2015 /PRNewswire/ -- Oxis Biotech, Inc. (OXIS), a wholly owned subsidiary of Oxis International, Inc.
- Large; stout; burly.
More Images (1 images) »